Dacarbazine

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 duh-KAR-buh-zeen

This page contains brief information about dacarbazine and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
DTIC-Dome
FDA Approved
Yes

Use in Cancer

Dacarbazine is approved to be used alone or with other drugs to treat:

Dacarbazine is also being studied in the treatment of other types of cancer.

More About Dacarbazine

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Dacarbazine - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results

Clinical Trial Results: Nivolumab Improves Overall Survival in Patients With Metastatic Melanoma Without a BRAF Mutation - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trials Accepting Patients

Find Clinical Trials for Dacarbazine - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: August 13, 2009
  • Updated: January 8, 2015